BTSG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BrightSpring Health Services Inc (BTSG) is not a strong buy at this time for a beginner investor with a long-term focus. While the company has positive analyst ratings and price target increases, the recent financial performance shows significant declines in net income, EPS, and gross margin. Additionally, no strong trading signals or significant insider or hedge fund activity suggests a compelling entry point. The technical analysis indicates a neutral trend, and options data reflects low bearish sentiment, but these factors do not outweigh the financial concerns.
The MACD is positive but contracting, RSI is neutral at 50.655, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 38.107, and resistance is at 41.102. Overall, the technical indicators suggest a neutral to slightly bullish trend.
Analysts have consistently raised price targets, with the most recent target at $
Hedge funds like Braidwell have recently acquired a significant position in the stock.
The company's revenue grew 28.17% YoY in Q3 2025.
Financial performance shows a steep decline in net income (-778.44% YoY) and EPS (-750.00% YoY).
Gross margin dropped by 5.31% YoY, indicating potential profitability issues.
No significant insider or hedge fund trading trends in the last quarter.
In Q3 2025, revenue increased by 28.17% YoY to $3.33 billion. However, net income dropped by -778.44% YoY to $55.8 million, and EPS fell by -750.00% YoY to 0.26. Gross margin also declined to 11.76%, down 5.31% YoY.
Analysts are positive on the stock, with multiple firms raising price targets recently. The highest target is $55, and the lowest is $43. Analysts highlight strong growth in the specialty business and positive momentum in pharmacy solutions.
